NCT00634361已完成2 期
Ethyl-EPA Treatment of Prodromal Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 7
- 主要终点
- conversion to psychosis
研究概览
简要总结
This is an open-label trial of an omega-3 fatty acid for symptoms of the schizophrenia prodrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 14 Years 至 35 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •meets criteria for schizophrenia prodrome
排除标准
- •any lifetime antipsychotic treatment
研究组 & 干预措施
A
Experimental
干预措施: ethyl-eicosapentaenoic acid (Drug)
结局指标
主要结局
conversion to psychosis
时间窗: one year
次要结局
未报告次要终点
研究者
相似试验
Unknown
4 期
Omega-3 Fatty Acids Efficacy in First-episode of SchizophreniaSchizophreniaNCT02210962Medical University of Lodz80
已完成
1 期
Efficacy of Omega-3 in the treatment of SchizophreniaSchizophrenia.The Schizophrenic Disorders Are Characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted.IRCT201202117373N2Arak University Of Medical Sciences60
已完成
不适用
Effects of Omega-3 fatty acids for psychotic disordersSchizophrenia, at-risk mental state (ARMS)schizophreniaJPRN-jRCTs041190054Higuchi Yuko
已完成
不适用
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum DisordersAutismNCT00467818University of Medicine and Dentistry of New Jersey17
已完成
4 期
Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for PsychosisProdromeSchizophreniaNCT00396643Medical University of Vienna81